Latest News of SNDX
Syndax Pharmaceuticals Inc (SNDX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
By Yahoo! Finance |
2 weeks ago
The CEO expects a high percentage of patients to restart maintenance therapy post-approval, emphasizing data gathering in the real world. Selling royalty stream boosts funds for drug development, and ...